The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Antitumor activity of osimertinib in NSCLC harboring EGFR exon 20 insertions.
 
Jonathan Riess
No Relationships to Disclose
 
Nicolas Floch
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Matthew Martin
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Jonathon Orme
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Anna Staniszewska
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Ludovic Menard
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Maria Emanuela Cuomo
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Daniel O'Neill
Employment - AstraZeneca
 
Richard Ward
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Raymond Finlay
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Darren McKerrecher
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Mingshan Cheng
No Relationships to Disclose
 
Daniel Vang
No Relationships to Disclose
 
Rebekah Tsai
No Relationships to Disclose
 
Chunting Ye
No Relationships to Disclose
 
James G. Keck
No Relationships to Disclose
 
David R. Gandara
Consulting or Advisory Role - ARIAD; AstraZeneca; Boehringer Ingelheim; Celgene; Clovis Oncology; Genentech; Guardant Health; Lilly; Merck; Mirati Therapeutics; Novartis; Pfizer; Response Genetics; Sanofi; Synta
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Genentech (Inst); Johnson & Johnson (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst)
 
Philip C. Mack
Honoraria - Guardant Health
Consulting or Advisory Role - Apton Biosystems; AstraZeneca; MolecularMD; Novartis
Research Funding - Boehringer Ingelheim
Travel, Accommodations, Expenses - Guardant Health
 
Darren Cross
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca